
Dr. Charles STACEY
CEO and President,
Cerecin
Dr. Stacey has over 20 years of experience in healthcare; working as a healthcare provider, executive, entrepreneur, and investor. He has been the CEO and President of Cerecin since Feb 2015. Prior to joining Cerecin, he was with Inventages, a Nestle affiliated venture capital and private equity group, with$ 1.5Bn under management. At Inventages, he supported the neuroscience, digital health and Asia interest. Prior to Inventages, Dr. Stacey worked in VC in the USA, for a neuro-medical device company and a ran an orthopaedics medical device company that spun out of his surgical practice. Dr Stacey originally trained and practiced as a trauma and reconstructive surgeon at King College London. He is a member of the Royal College of Surgeons & General Medical Council, UK. Dr Stacey serves on the Board of Governors for Medical Affairs and as an advisor and investor in several life science companies. His undergraduate degree and research was in neuroscience at University College London.
Industry Advisory Panel
Dr. Fabien CABIROL
Senior Director,
Procter & Gamble
Dr. Alice CHEN
Partner and Head APAC,
Accelerator Life Science Partners
Todd DOLLINGER
Founder and Chair Emeritus,
The Trendlines Group
Arif FAHIM
Director of Asia Pacific,
Abbott
Dr. Joaquin LASSO
Senior Vice President,
Smith & Nephew
Dr. Julian SHAM
APAC Clinical Digital Transformation Lead,
Roche Diagnostics